Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,080Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Polfa Tarchomin

02 1Capital Farma

03 3Accord healthcare

04 6Actavis Inc

05 5Alembic Pharmaceuticals Limited

06 4Alphapharm PTY Ltd

07 2Apotex Inc

08 3Aurobindo Pharma Limited

09 3Avery Pharmaceuticals

10 5Barr Laboratories

11 3Biodeal Pharmaceuticals

12 4CPS Cito Pharma Services GmbH

13 3Chartwell Pharmaceuticals llc

14 7Cheplapharm Arzneimittel Gmbh

15 5ENDO OPERATIONS

16 16F. Hoffmann-La Roche

17 1Halewood Laboratories Pvt. Ltd

18 4Indo Pharma

19 3Intas Pharmaceuticals

20 2LABORATOIRE RIVA INC.

21 2MS Pharma

22 3NORVIUM BIOSCIENCE

23 4Neuraxpharm

24 4ORIFARM GROUP AS

25 3PRO DOC LIMITEE

26 7Pharmaco

27 4Pharmaco Distribution

28 10Pharmascience Inc.

29 3Prinston

30 3R Key Enterprises

31 12RELIANCE FORMULATION PVT. LTD

32 4Ram Pharma

33 3Rubicon Research

34 3Sandoz B2B

35 8Sun Pharmaceutical Industries Limited

36 6Teva Pharmaceutical Industries

37 1Vaishali Pharma Ltd

38 3Verve Human Care Laboratories

39 1XL Laboratories Private Limited

40 7Zim Laboratories

41 5Zota Healthcare Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Available

Registration Country : Poland

Clonazepam

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Available

Registration Country : Poland

Polfa Tarchomin

02

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

Regulatory Info :

Registration Country : Spain

Clonazepam

Brand Name :

Dosage Form : Oral Drop solution

Dosage Strength : 2.5MG/1ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

Capital Farma

03

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Available

Registration Country : Poland

Clonazepam

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Available

Registration Country : Poland

Polfa Tarchomin

04

arrow
Pharma Manufacturing 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Available

Registration Country : Poland

Clonazepam

Brand Name :

Dosage Form : Solution for Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Available

Registration Country : Poland

Polfa Tarchomin

05

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 1996-10-31

Application Number : 74869

Regulatory Info : RX

Registration Country : USA

blank

06

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 1996-10-31

Application Number : 74869

Regulatory Info : RX

Registration Country : USA

blank

07

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 1996-10-31

Application Number : 74869

Regulatory Info : RX

Registration Country : USA

blank

08

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17533

Regulatory Info : RX

Registration Country : USA

blank

09

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17533

Regulatory Info : RX

Registration Country : USA

blank

10

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17533

Regulatory Info : RX

Registration Country : USA

blank

11

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 0.125MG

Packaging :

Approval Date : 1997-04-09

Application Number : 17533

Regulatory Info : DISCN

Registration Country : USA

blank

12

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 1997-04-09

Application Number : 17533

Regulatory Info : DISCN

Registration Country : USA

blank

13

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

14

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

15

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

16

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

17

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

18

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 1996-09-10

Application Number : 74569

Regulatory Info : RX

Registration Country : USA

blank

19

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 1996-09-10

Application Number : 74569

Regulatory Info : RX

Registration Country : USA

blank

20

Pharma Manufacturing 2024
Not Confirmed
arrow
arrow
Pharma Manufacturing 2024
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 1996-09-10

Application Number : 74569

Regulatory Info : RX

Registration Country : USA

blank